(Q47742637)

5 February 2018

title

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome (English)

1 reference

5 February 2018

0 references

1 reference

1

1 reference

5 February 2018

Paul Kay-Sheung Chan

2

1 reference

5 February 2018

David Shu-cheong Hui

8

1 reference

5 February 2018

author name string

Margaret Ip

3

1 reference

5 February 2018

Eric Wong

4

1 reference

5 February 2018

Jenny Ho

5

1 reference

5 February 2018

Catherine Ho

6

1 reference

5 February 2018

C S Cockram

7

1 reference

5 February 2018

publication date

19 August 2005

1 reference

5 February 2018

Journal of Clinical Virology

published in

1 reference

5 February 2018

volume

35

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

179-184

1 reference

5 February 2018

An interferon-gamma-related cytokine storm in SARS patients

cites work

1 reference

12 December 2020

Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.

1 reference

12 December 2020

Natural course of severe acute respiratory syndrome-associated coronavirus immunoglobulin after infection.

1 reference

12 December 2020

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

1 reference

12 December 2020

Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity

1 reference

12 December 2020

Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus

1 reference

12 December 2020

Serology of severe acute respiratory syndrome: implications for surveillance and outcome

1 reference

12 December 2020

Profile of specific antibodies to the SARS-associated coronavirus.

1 reference

12 December 2020

The severe acute respiratory syndrome

1 reference

12 December 2020

Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan

1 reference

12 December 2020

Immunofluorescence assay for serologic diagnosis of SARS

1 reference

12 December 2020

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

1 reference

12 December 2020

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.

1 reference

12 December 2020

Asymptomatic severe acute respiratory syndrome-associated coronavirus infection

1 reference

12 December 2020

Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome

1 reference

12 December 2020

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

1 reference

12 December 2020

Use of convalescent plasma therapy in SARS patients in Hong Kong.

1 reference

12 December 2020

Asymptomatic SARS coronavirus infection among healthcare workers, Singapore

1 reference

12 December 2020

Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak.

1 reference

12 December 2020

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus.

1 reference

12 December 2020

Laboratory diagnosis of SARS.

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

12 December 2020

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes

1 reference

12 December 2020

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

1 reference

12 December 2020

Short-term outcome of critically ill patients with severe acute respiratory syndrome

1 reference

12 December 2020

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

1 reference

12 December 2020

Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards

1 reference

12 December 2020

Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS

1 reference

12 December 2020

10.1016/J.JCV.2005.07.005

Identifiers

DOI

1 reference

5 February 2018

release_lfdbby2mj5bdtnnt64xaycuqsi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lfdbby2mj5bdtnnt64xaycuqsi

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/lfdbby2mj5bdtnnt64xaycuqsi

24 November 2022

mapped directly with Wikidata item

PubMed ID

16112612

1 reference

5 February 2018